EP Wealth Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$470K Hold
11,096
– – ﹤0.01% 1017
2026
Q2
$374K Buy
+11,096
New +$333K ﹤0.01% 1169

Other funds holding IDNA

EP Wealth Advisors's IDNA Position: Q3 2026 in Review

EP Wealth Advisors held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q3 2026 at 11,096 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

EP Wealth Advisors first reported a position in IDNA in Q2 2026 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.

  • EP Wealth Advisors held 11,096 shares of iShares Genomics Immunology and Healthcare ETF worth $470K as of Q3 2026.
  • EP Wealth Advisors left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q3 2026.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of EP Wealth Advisors's portfolio in Q3 2026, its #1017 holding.
  • EP Wealth Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2026 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.

Based on EP Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.